Fidelity Investments
BDSX icon

Fidelity Investments’s Biodesix BDSX Stock Holding History

Fidelity Investments’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15 Hold
1
– – ﹤0.01% 5366
2025
Q4 		$7 Hold
1
– – ﹤0.01% 5381
2025
Q3 		$8 Hold
1
– – ﹤0.01% 5338
2025
Q2 		$8 Hold
1
– – ﹤0.01% 5294
2025
Q1 		$17 Buy
+1
New +$19 ﹤0.01% 5228
2022
Q3 		– Sell
-13
Closed – – 4853
2022
Q2 		$0 Buy
13
+2
+18% +$65 ﹤0.01% 4915
2022
Q1 		$0 Buy
+11
New +$719 ﹤0.01% 4952

Other funds holding BDSX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Fidelity Investments's BDSX Position: Q1 2026 in Review

Fidelity Investments held its Biodesix (BDSX) position steady in Q1 2026 at 1 share worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #5366.

Fidelity Investments first reported a position in BDSX in Q1 2022 and has held it in 7 quarters since. The position peaked at $17 in Q1 2025. 40 funds tracked by Wall St. Rank hold BDSX as of Q1 2026.

  • Fidelity Investments held 1 share of Biodesix worth $15 as of Q1 2026.
  • Fidelity Investments left its Biodesix share count unchanged in Q1 2026.
  • Biodesix made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5366 holding.
  • Fidelity Investments first reported a position in Biodesix in Q1 2022 and has held it in 7 quarters since.
  • Fidelity Investments's Biodesix position peaked at $17 in Q1 2025.
  • 40 funds tracked by Wall St. Rank held Biodesix as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.